Latest Reports

Medical Device Development (PH210)

Navigate medical device development and commercialization to ensure that you have human and financial resources to ensure successful US launches.

Building World-Class HEOR Teams (PH211)

Benchmark health economics and outcomes research (HEOR) team resources and study metrics to cultivate payer relationships and win reimbursement.

Investigator-Initiated Trial Management (PH212)

Use Investigator-Initiated Trial Management to accelerate IIT practices while upholding transparency requirements. Build the perfect IIT budget and ensure fair market value compliance. This report delves into the key factors impacting IIT management success: proposal selection, evaluation team structure, resources, performance metrics and compliance.

Global Key Opinion Leader Compensation 2015 (PH208)

Use this groundbreaking report to stay compliant and keep pace with the rapid, worldwide formalization of FMV processes and legislation. Smart management depends on three key points — standardized rate cards, clear KOL scoring systems and regular access to reliable FMV rates — and this report covers all three.

Capture and Communicate the Full Value of Medical Science Liaisons (PH207)

Medical science liaisons serve as the company’s voice when communicating with key opinion leaders. Despite their role in shaping these important relationships, MSL teams struggle to prove their value to company strategy.

US Government Drug Reimbursement (PH204)

In the United States, attaining formulary position and negotiating prices have become increasingly complex and competitive, especially in light of new guidelines under the Affordable Care Act (ACA). Success guarantees that treatments reach patients — and that brands meet or exceed revenue expectations. This report focuses exclusively on US government reimbursement strategy and trends. This study provides actionable insights — drawn from the data and experiences of top-performing life science executives — for winning and maintaining formulary position. Data show US government reimbursement pricing systems and payer relationship management strategies.

Risk-Based Monitoring (PH205)

Simplify risk-based monitoring and use it to facilitate trial processes and anticipate issues related to RBM implementation. The report contains benchmarks comparing in-house and outsourced responsibilities of key clinical roles — trial monitors, data managers, statisticians, and drug safety — for traditional and RBM trials.

Pharmaceutical Lifecycle Management Strategy (PH199)

Increasing focus on LCM throughout a product’s lifecycle will help companies maximize product sales now and better prepare a counter-generics strategy in the future. This study includes data from 100+ pharmaceutical lifecycle management strategies from life science companies of all sizes and across multiple geographic locations.

Medical Information and Call Center Performance (PH206)

Medical information call center staffing benchmarks, including number of agents per manager and outsourcing levels, allow teams to adjust staffing to meet fluctuating project demands.

Clinical Investigator FMV and Compensation Benchmarks (PH202)

Our new clinical investigator FMV study focuses on promoting transparency by building accurate calculation procedures, establishing investigator payment schedules to keep trials on track and organizing successful investigator meetings while staying within a budget.  The report also includes key performance indicators, such as pass-through/direct cost benchmarks, average investigator compensation across nine therapeutic areas, annual compensation limits for principal investigators, and cost-per-attendee metrics for investigator meetings.